7 completed, 2 recruiting, 1 suspended, 1 terminated. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 7, Recruiting 2, Suspended 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow TAU: new trials by email Literature Review of TAU trials Research Report on TAU
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI) Quetiapine Fumarate, TAU - Mild Traumatic Brain Injury | Phase 3 | Recruiting | Foundation for Advancing Veterans' Health Research | 146 | 2024-07-09 | 2025-07-11 |
| Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment MORE, SMP, TAU - Opioid Use, Pain | Phase 3 | Recruiting | Rutgers, The State University of New Jersey | 450 | 2023-09-04 | 2025-07-30 |
| Integrated Digital Intervention for Alcohol Use Disorder Mobile health application, Medical Management - Alcohol Use Disorder | Phase 2 / Phase 3 | Completed | Quit Genius | 242 | 2023-01-01 | 2025-11-20 |
| Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment Buprenorphine/Naloxone, Treatment as usual - Opioid Use | Phase 3 | Suspended | Friends Research Institute, Inc. | 320 | 2022-07-01 | 2026-11-12 |
| A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic OTX-202, OTX-000, Treatment as Usual - Suicide, Attempted, Suicidal Ideation | Phase 2 / Phase 3 | Terminated | Oui Therapeutics, Inc. | 356 | 2022-04-07 | 2025-06-12 |
| Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia Vortioxetine, Usual Antipsychotic Treatment - Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic Disorder | Phase 2 / Phase 3 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 37 | 2022-01-20 | 2024-02-26 |
| Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome MBSR, FibroQol, TAU - Fibromyalgia Syndrome | Phase 3 | Completed | Fundació Sant Joan de Déu | 225 | 2016-01-01 | 2019-10-14 |
| Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders Integrated Cognitive Behavioral Therapy, Treatment-as-usual - Stress Disorder, Post-Traumatic, Substance-Related Disorders | Phase 3 | Completed | Dartmouth-Hitchcock Medical Center | 56 | 2011-02-01 | 2015-10-26 |
| Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment Cognitive Behavioral Therapy, Individual Addiction Counseling, Treatment-as-usual - Stress Disorders, Post-Traumatic, Substance-Related Disorders | Phase 3 | Completed | Dartmouth-Hitchcock Medical Center | 443 | 2010-12-01 | 2015-02-16 |
| School-based Treatment for Anxious Children Cognitive behavioral therapy (CBT), Treatment as usual (TAU) - Anxiety Disorders | Phase 3 | Completed | Johns Hopkins University | 40 | 2006-10-01 | 2013-09-24 |
| Identification and Therapy of Postpartum Depression Care Management for Postpartum Depression, TAU - Depression | Phase 3 | Completed | University of Pittsburgh | 628 | 2006-08-01 | 2013-10-07 |
| Brief Strategic Family Therapy for Adolescent Drug Abusers Brief Strategic Family Therapy (BSFT), Treatment as Usual - Substance Abuse | Phase 3 | Completed | University of Miami | 480 | 2004-08-01 | 2015-07-07 |
Stress Disorders, Post-Traumatic (3) · Substance-Related Disorders (3) · Behavior, Addictive (2) · Alcoholism (1) · Anxiety Disorders (1) · Brain Concussion (1) · Depression (1) · Depression, Postpartum (1) · Fibromyalgia (1) · Pain (1) · Post-Concussion Syndrome (1) · Suicidal Ideation (1) · Suicide, Attempted (1)
Dartmouth-Hitchcock Medical Center (2) · Foundation for Advancing Veterans' Health Research (1) · Friends Research Institute, Inc. (1) · Fundació Sant Joan de Déu (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Johns Hopkins University (1) · Oui Therapeutics, Inc. (1) · Quit Genius (1) · Rutgers, The State University of New Jersey (1) · University of Miami (1) · University of Pittsburgh (1)
United States (10) · Spain (2) · Puerto Rico (1)
Mark P. McGovern, Ph.D. (2) · Benedicto Crespo Facorro, Professor (1) · Eric Garland, Ph (1) · Golda Ginsburg, PhD (1) · Jose Szapocznik, Ph.D. (1) · Juan V. Luciano, PhD (1) · Katherine L. Wisner, MD, RN (1)
PMID 15850502, PMID 19032530, PMID 19470315, PMID 21075957, PMID 21381158, PMID 21967492, PMID 22439295, PMID 23487258, PMID 23795871, PMID 25462653, PMID 25846251, PMID 26059839, PMID 26286351, PMID 26921267, PMID 27920321, PMID 28796940, PMID 29540927, PMID 30538599, PMID 31356450, PMID 35222735, PMID 38907675, PMID 39566056, PMID 40779267
5RC2DA028864 (1), R01DA027650 (1), R01DA030102 (1), R01DA056537 (1), R01MH071825 (1), R34MH074552 (1), R42MH123357 (1), U10DA013720 (1)